Simplex Trading
EDIT icon

Simplex Trading’s Editas Medicine EDIT Stock Holding History

Simplex Trading’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86K Buy
34,800
+13,800
+66% +$29.2K ﹤0.01% 5270
2025
Q4 		$43K Sell
21,000
-8,300
-28% -$24K ﹤0.01% 5797
2025
Q3 		$101K Buy
29,300
+4,600
+19% +$12.8K ﹤0.01% 5734
2025
Q2 		$54K Sell
24,700
-10,500
-30% -$17.2K ﹤0.01% 5850
2025
Q1 		$40K Buy
35,200
+6,200
+21% +$9.12K ﹤0.01% 5996
2024
Q4 		$36K Sell
29,000
-100
-0.3% -$255 ﹤0.01% 6194
2024
Q3 		$99K Sell
29,100
-33,500
-54% -$146K ﹤0.01% 5238
2024
Q2 		$292K Buy
62,600
+18,300
+41% +$103K ﹤0.01% 4262
2024
Q1 		$328K Buy
44,300
+2,400
+6% +$19.9K ﹤0.01% 4285
2023
Q4 		$424K Buy
41,900
+12,400
+42% +$109K ﹤0.01% 3871
2023
Q3 		$230K Sell
29,500
-9,900
-25% -$84.9K ﹤0.01% 4197
2023
Q2 		$324K Sell
39,400
-2,200
-5% -$19.2K ﹤0.01% 3747
2023
Q1 		$301K Buy
41,600
+20,100
+93% +$179K ﹤0.01% 3839
2022
Q4 		$190K Sell
21,500
-31,900
-60% -$350K ﹤0.01% 4289
2022
Q3 		$653K Sell
53,400
-3,000
-5% -$46.7K ﹤0.01% 3150
2022
Q2 		$667K Sell
56,400
-25,100
-31% -$336K ﹤0.01% 3093
2022
Q1 		$1.55M Sell
81,500
-30,200
-27% -$561K ﹤0.01% 2372
2021
Q4 		$2.96M Sell
111,700
-2,400
-2% -$82.6K ﹤0.01% 1644
2021
Q3 		$6.45M Buy
114,100
+6,600
+6% +$362K 0.01% 999
2021
Q2 		$6.09M Buy
+107,500
New +$3.97M 0.01% 1021
2021
Q1 		– Sell
-550
Closed -$3.86M – 9077
2020
Q4 		$3.86M Buy
550
+146
+36% +$6K 0.01% 1184
2020
Q3 		$1.13M Sell
404
-1
-0.2% -$33 ﹤0.01% 2103
2020
Q2 		$1.2M Sell
405
-456
-53% -$11.9K ﹤0.01% 1980
2020
Q1 		$1.71M Sell
861
-403
-32% -$10.2K ﹤0.01% 1405
2019
Q4 		$3.74M Buy
1,264
+1,103
+685% +$27.5K 0.01% 989
2019
Q3 		$366K Buy
161
+56
+53% +$1.39K ﹤0.01% 2950
2019
Q2 		$259K Sell
105
-535
-84% -$12.8K ﹤0.01% 3213
2019
Q1 		$1.56M Buy
640
+116
+22% +$2.63K ﹤0.01% 1591
2018
Q4 		$1.19M Sell
524
-59
-10% -$1.61K ﹤0.01% 1488
2018
Q3 		$1.85M Buy
583
+61
+12% +$1.97K 0.01% 1315
2018
Q2 		$1.87M Sell
522
-44
-8% -$1.56K 0.01% 1202
2018
Q1 		$367K Buy
566
+237
+72% +$8.45K 0.02% 876
2017
Q4 		$96K Buy
329
+195
+146% +$4.91K ﹤0.01% 1834
2017
Q3 		$14K Sell
134
-242
-64% -$4.61K ﹤0.01% 3471
2017
Q2 		$87K Buy
376
+54
+17% +$973 ﹤0.01% 1872
2017
Q1 		$55K Buy
322
+274
+571% +$5.68K ﹤0.01% 2265
2016
Q4 		$2K Sell
48
-64
-57% -$971 ﹤0.01% 5013
2016
Q3 		$26K Buy
+112
New +$2.29K ﹤0.01% 2700

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Simplex Trading's EDIT Position: Q1 2026 in Review

Simplex Trading reduced its Editas Medicine (EDIT) stake by 96% in Q1 2026, selling an estimated $283K and leaving 5,981 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #7009.

Simplex Trading first reported a position in EDIT in Q3 2016 and has held it in 33 quarters since. The position peaked at $5.42M in Q3 2021. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Simplex Trading held 5,981 shares of Editas Medicine worth $14.8K as of Q1 2026.
  • Simplex Trading sold 133,791 Editas Medicine shares in Q1 2026, an estimated $283K.
  • Editas Medicine made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7009 holding.
  • Simplex Trading first reported a position in Editas Medicine in Q3 2016 and has held it in 33 quarters since.
  • Simplex Trading's Editas Medicine position peaked at $5.42M in Q3 2021.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.